• $5.0M
    Market Cap
  • 12.85%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
0
N/A
N/A
N/A
0
N/A
N/A
N/A
Cost of Revenue
0
-100.00%
529,992
N/A
0
N/A
N/A
N/A
Gross Profit
0
+100.00%
-529,992
N/A
0
N/A
0
N/A
Sales and Marketing Expense
2,975
+1,303.30%
212
-92.72%
2,911
-79.91%
14,491
+866.07%
Research and Development Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Depreciation and Amortization Expense
22,487
-0.44%
22,586
-56.89%
52,392
-52.98%
111,426
-14.15%
Total Operating Expenses
1.3M
+150.51%
529,992
-31.22%
770,568
-48.81%
1.5M
-46.27%
Operating Profit
-1.3M
+150.51%
-529,992
-31.22%
-770,568
-48.81%
-1.5M
-46.27%
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
-43,857
+765.03%
-5,070
-88.83%
-45,374
-61.26%
-117,124
+198.45%
Interest Income and Expense and Net
-43,857
+765.03%
-5,070
-88.83%
-45,374
-61.26%
-117,124
+198.45%
Total Nonoperating Income and Expense
-44,494
-11.59%
-50,325
-106.80%
739,991
+3,341.17%
-22,831
-43.59%
Income before Taxes
-1.4M
+158.90%
-529,992
-31.22%
-770,568
-49.57%
-1.5M
-46.23%
Income Taxes
33
-91.73%
399
-59.29%
980
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-1.4M
+168.68%
-510,716
+1,518.39%
-31,557
-97.93%
-1.5M
-46.23%
Net Income from Continuing Operations Applicable to Common
-1.4M
+168.68%
-510,716
+1,518.39%
-31,557
-97.93%
-1.5M
-46.23%
Basic EPS and Net Income
N/A
N/A
-0.004
N/A
N/A
N/A
-0.01
-50.00%
Diluted EPS and Net Income
-0.01
+150.00%
-0.004
N/A
N/A
N/A
-0.01
-50.00%
Basic Weighted Average Shares
135.9M
+9.50%
124.1M
N/A
N/A
N/A
122.1M
+4.58%
Diluted Weighted Average Shares
135.9M
+9.50%
124.1M
N/A
N/A
N/A
122.1M
+4.58%
Balance Sheet
Cash and Cash Equivalents
33,130
-79.21%
159,355
-45.13%
290,409
-8.05%
315,826
+1,506.93%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
33,130
-79.21%
159,355
-45.13%
290,409
-8.05%
315,826
+1,506.93%
Total Current Assets
47,705
-74.88%
189,891
-40.64%
319,886
-6.49%
342,075
+716.06%
Accumulated Depreciation
148,304
+15.49%
128,417
+18.43%
108,431
-73.61%
410,942
-27.80%
Property and Plant and Equipment and Net
476,467
-4.01%
496,354
-3.87%
516,340
-57.29%
1.2M
-35.59%
Total Long-Term Assets
476,467
-4.01%
496,354
-3.87%
516,340
-57.29%
1.2M
-35.59%
Total Assets
559,906
-24.17%
738,366
-18.33%
904,062
-44.67%
1.6M
-16.61%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
0
N/A
N/A
N/A
3,661
-99.49%
710,891
+7.27%
Total Current Liabilities
1.2M
+30.11%
959,372
+47.88%
648,753
-55.69%
1.5M
+9.11%
Total Long-Term Debt
502,985
+18.82%
423,328
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
4,751
-74.37%
18,538
-41.43%
31,653
-28.27%
44,130
N/A
Total Liabilities
1.2M
+30.11%
959,372
+47.88%
648,753
-55.69%
1.5M
+9.11%
Retained Earnings
-86.3M
+1.62%
-84.9M
+0.61%
-84.4M
+0.04%
-84.4M
+1.84%
Total Stockholders Equity
-688,361
+211.47%
-221,006
-186.56%
255,309
+50.36%
169,796
-72.50%
Total Shares Outstanding
147.4M
+17.54%
125.4M
+1.58%
123.5M
0.00%
123.5M
+3.57%
Cash Flow
Cash from Operating Activities
-195,136
-53.04%
-415,524
-61.31%
-1.1M
+32.12%
-812,975
+42.90%
Capital Expenditures
N/A
N/A
N/A
N/A
10,000
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
N/A
N/A
1.6M
+29.76%
1.3M
+563.45%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
70,103
-75.43%
285,269
+148.52%
-587,979
+295.50%
-148,667
-117.52%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Return on Assets
-211.39%
+239.91%
-62.19%
+2,400.72%
-2.49%
-97.08%
-85.06%
-43.46%
Return on Equity
301.79%
+110.14%
-2,977.68%
+19,956.14%
-14.85%
-96.18%
-388.19%
+2.40%
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.04
-80.70%
0.20
-59.87%
0.49
+111.00%
0.23
+649.04%
Cash Ratio
0.03
-84.05%
0.17
-62.89%
0.45
+107.51%
0.22
+1,377.40%
Debt-to-Equity Ratio
-0.73
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
0.90
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow